Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, reposted from Mater Dei General Hospital on LinkedIn:
”Would you take a life-saving drug knowing that in one case out of three this does not work? Probably not.
In the heart of Rome, one of the first centers in Italy to finally offer the possibility of predicting the response to the most widely used anti-caking drug, clopidogrel, with a simple and rapid genetic test.
The result of the test is integrated with the most up-to-date international recommendations on the subject, to which I had the honor of contributing, to offer a personalized assessment and improve the prognosis of patients in each specific clinical context.
After years of scientific research, it is time to turn science into real benefits for a more targeted and personalized care of cardiovascular patients.”
Mater Dei General Hospital shared on LinkedIn:
”What is the Genomadix Cube test?
It is a simple and non-invasive genetic test that helps to understand how our body responds to some fundamental drugs in cardiology, such as antiplatelet drugs that inhibit P2Y12 (clopidogrel, prasugrel or ticagrelor)
Let’s find out more with Dr. Mattia Galli
Info and reservations
Tel. 06 83 803”
Read the full article in JACC.
Article: International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Authors: Dominick J. Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L. Bhatt, Laurent Bonello, Davide Capodanno, Larisa H. Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi, Tobias Geisler, C. Michael Gibson, Diana A. Gorog, Paul A. Gurbel, Young-Hoon Jeong, Rossella Marcucci, Jolanta M. Siller-Matula, Roxana Mehran, Franz-Josef Neumann, Naveen L. Pereira, Konstantinos D. Rizas, Fabiana Rollini, Derek Y.F. So, Gregg W. Stone, Robert F. Storey, Udaya S. Tantry, Jurrien Ten Berg, Dietmar Trenk, Marco Valgimigli, Ron Waksman, Dirk Sibbing
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia